Megafine Pharma Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1995.

1995 Mumbai, Maharashtra, India Active

Last Updated: February 22, 2026

About Megafine Pharma Private Limited

Megafine Pharma Private Limited, a active private limited company, was established on 22 August 1995 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239MH1995PTC092028. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.53 Cr.

It upholds a compliant status. Employing 758 professional, Its leadership includes Rohit Brijmohan Mantri (Nominee Director), Shailesh Jethmal Sanghvi (Managing Director), Hari Prasshanth (Nominee Director). Past directors included Ashok Kirtilal Jhaveri, Rohit Brijmohan Mantri, Hasmukh Purushottam Gandhi. It holds ₹48.00 Cr open charges and ₹48.75 Cr settled loans. Its latest AGM occurred on 17 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sethna Building,4Th Floor, 55 Maharshi Karve Road, Marine Lines, Mumbai, Maharashtra, 400002.

Company Details

CIN/LLPIN
U24239MH1995PTC092028
Registration Number
092028
Incorporation Date
22 August 1995
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹1.53 Cr
ROC Code
Roc Mumbai I
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 22-02-2026
Paid Up Capital ₹ 1.53 Cr as on 22-02-2026
Company Age 30 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 48.00 Cr as on 22-02-2026
Satisfied Charges ₹ 48.75 Cr as on 22-02-2026
Revenue Growth **** 7.00% (FY 2024)
Profit Growth **** -7.66% (FY 2024)
Ebitda **** -10.91% (FY 2024)
Net Worth 15.36% (FY 2024)
Total Assets **** 7.43% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Megafine Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Megafine Pharma Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Rohit Brijmohan Mantri	Nominee Director	21 Feb 2025	Current
Shailesh Jethmal Sanghvi	Managing Director	22 Aug 1995	Current
Hari Prasshanth	Nominee Director	06 Mar 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Whole-Time Director	24 Dec 2018	Past
Pramod Abcsdd	Additional Director	21 Feb 2025	Past
Pramod Abcsdd	Director	20 Aug 2014	Past
Pramod Abcsdd	Additional Director	27 Sep 2019	Past
Pramod Abcsdd	Director	20 Aug 2014	Past
Pramod Abcsdd	Additional Director	03 Apr 2025	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Megafine Pharma.

Mega Fine Pharma Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 7% increase. The company also saw a slight decrease in profitability, with a 7.66% decrease in profit. The company's net worth Soared by an impressive increase of 15.36%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.00%

*******

Revenue from Operations

*******

6.36%

*******

Total Assets

*******

7.43%

*******

Profit or Loss

*******

-7.66%

*******

Net Worth

*******

15.36%

*******

EBITDA

*******

-10.91%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Megafine Pharma?

In 2024, Megafine Pharma had a promoter holding of 49.24% and a public holding of 50.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹480,000,000.00

Satisfied Charges

₹487,523,000.00

Charges Breakdown by Lending Institutions

State Bank Of India : 39.50 Cr
Hdfc Bank Limited : 8.50 Cr

Latest Charge Details

Date	Lender	Amount	Status
26 Apr 2012	Hdfc Bank Limited	₹8.50 Cr	Open
13 Jun 2006	State Bank Of India	₹39.50 Cr	Open
22 Nov 2019	Hdfc Bank Limited	₹44.50 Cr	Satisfied
29 Sep 2003	Canara Bank	₹2.70 Cr	Satisfied
05 Jun 2002	Canara Bank	₹0.80 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Megafine Pharma?

Megafine Pharma has a workforce of 758 employees as of Dec 12, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Megafine Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megafine Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Megafine Pharma

Recent Activity within the Organization

Annual General Meeting

The activity Megafine Pharma Private Limited last Annual general meeting of members was held on 17 Sep 2025 as per latest MCA records. was completed.
17 Sep 2025
Balance Sheet

The activity Megafine Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was completed.
31 Mar 2025
Director Appointment

Hari Prasshanth was appointed as a Nominee Director was appointed as a Nominee Director on 06 Mar 2025 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
06 Mar 2025
Director Appointment

The activity Rohit Brijmohan Mantri was appointed as a Nominee Director was appointed as a Nominee Director on 21 Feb 2025 & has been associated with this company since 1 year 4 months . was completed.
21 Feb 2025
Charges

Progress on A charge registered on 22 Nov 2019 via Charge ID 100304683 with Hdfc Bank Limited was fully satisfied on 14 Aug 2024. was documented.
14 Aug 2024
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 8.50 Cr registered on 26 Apr 2012 with Charge ID 10350830 was modified on 01 Aug 2024. was documented.
01 Aug 2024

Explore recent activity and updates - View Recent Activity